ProjectAbstract The interstitial lung diseases (ILDs) are a family of closely related lung conditions characterized by alveolar inflammation, injury, and/or fibrosis not due to infection or neoplasia. Idiopathic pulmonary fibrosis (IPF), a fibroticILDaffectsnearly1in200olderadultsandcarriesapoorprognosis.Therapeuticoptionsarelimited, andtodatenostudyhastestedinterventionsthatpreventthedevelopmentofafibroticILD.Weareconducting studiesthatarepreparatorytoandrequisiteforfutureclinicaltrialsofpreventativeIPFandILDinterventions. To move toward this goal, in the previous award period, we established the construct validity of a novel quantitative computed tomographic (CT)-based measure, termed high attenuation areas (HAAs), as an imaging biomarker of early, mild alveolar inflammation, injury, and fibrosis in a large cohort of community dwelling adults enrolled in the Multi-Ethnic Study of Atherosclerosis (MESA), an ongoing NHLBI-funded prospective cohort study of 6,814 adults age 45 and older at enrollment in 2000 through 2002. These data strongly support HAA as a novel and relevant quantitative biomarker of the earliest biological changes in the lungparenchymathatlaterleadtoILD,yetadditionalworkisrequiredtomovethesefindingsintofutureclinical trialsandintotheclinic.Inthecurrentapplication,weproposetoexaminethepulmonaryhistopathologyand biologyofHAAinfirst-degreerelativesofadultswithclinicallydiagnosedILD.Toachievethesegoals,wewill initiate the Families At-Risk for ILD (FAR-ILD) study, a prospective study of adults with ILD and their first- degreerelativesdesignedtoidentifyadultswithsubclinicalILDandthoseat-riskforincidentILD.Wewillalso usetheMESAcohorttodevelopaclinicalpredictionmodelforincidentradiologicILD.Ourstudywillprovide strong evidence that will inform future studies of preventative interventions for adults at high risk of ILD. Our results will also help identify potential targetable pathways for prevention in at-risk adults and inform future phase2trialofapreventativeintervention,suchaspirfenidone,nintedanib,orN-acetylcysteine(whichmaybe effective in subsets of individuals), or perhaps by targeting a pathway identified through our study of the biologyofearlysubclinicalILD.

Public Health Relevance

Pulmonaryfibrosisreferstoafamilyoffataldiseasescharacterizedbyprogressivescarringofthewallsofthe airsacsofthelungs.Ourgoalistounderstandthebiologicalunderpinningsofpulmonaryfibrosisyearsbefore the first symptoms arise. Ultimately, the results of our study will be used to develop novel methods of preventingthedevelopmentandprogressionofpulmonaryfibrosis,akeysteptowardthepreventionofchronic lungdisease,agoalsetbytheNHLBI.

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Research Project (R01)
Project #
Application #
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Vuga, Louis J
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Columbia University (N.Y.)
Internal Medicine/Medicine
Schools of Medicine
New York
United States
Zip Code
Gannon, Whitney D; Lederer, David J; Biscotti, Mauer et al. (2018) Outcomes and Mortality Prediction Model of Critically Ill Adults With Acute Respiratory Failure and Interstitial Lung Disease. Chest 153:1387-1395
Bernstein, Elana J; Khanna, Dinesh; Lederer, David J (2018) Screening High-Resolution Computed Tomography of the Chest to Detect Interstitial Lung Disease in Systemic Sclerosis: A Global Survey of Rheumatologists. Arthritis Rheumatol 70:971-972
Oelsner, Elizabeth C; Smith, Benjamin M; Hoffman, Eric A et al. (2018) Associations between emphysema-like lung on CT and incident airflow limitation: a general population-based cohort study. Thorax 73:486-488
Madahar, Purnema; Duprez, Daniel A; Podolanczuk, Anna J et al. (2018) Collagen biomarkers and subclinical interstitial lung disease: The Multi-Ethnic Study of Atherosclerosis. Respir Med 140:108-114
Sack, Coralynn S; Doney, Brent C; Podolanczuk, Anna J et al. (2017) Occupational Exposures and Subclinical Interstitial Lung Disease. The MESA (Multi-Ethnic Study of Atherosclerosis) Air and Lung Studies. Am J Respir Crit Care Med 196:1031-1039
Manichaikul, Ani; Sun, Li; Borczuk, Alain C et al. (2017) Plasma Soluble Receptor for Advanced Glycation End Products in Idiopathic Pulmonary Fibrosis. Ann Am Thorac Soc 14:628-635
Restivo, Michaela D; Podolanczuk, Anna; Kawut, Steven M et al. (2017) Antacid use and subclinical interstitial lung disease: the MESA study. Eur Respir J 49:
Kim, John S; Podolanczuk, Anna J; Borker, Priya et al. (2017) Obstructive Sleep Apnea and Subclinical Interstitial Lung Disease in the Multi-Ethnic Study of Atherosclerosis (MESA). Ann Am Thorac Soc 14:1786-1795
Podolanczuk, Anna J; Oelsner, Elizabeth C; Barr, R Graham et al. (2017) High-Attenuation Areas on Chest Computed Tomography and Clinical Respiratory Outcomes in Community-Dwelling Adults. Am J Respir Crit Care Med 196:1434-1442
Sack, Coralynn; Vedal, Sverre; Sheppard, Lianne et al. (2017) Air pollution and subclinical interstitial lung disease: the Multi-Ethnic Study of Atherosclerosis (MESA) air-lung study. Eur Respir J 50:

Showing the most recent 10 out of 33 publications